Founders Financial Securities’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,343
Closed -$818K 317
2022
Q2
$818K Buy
16,343
+148
+0.9% +$7.86K 0.16% 115
2022
Q1
$831K Buy
+16,195
New +$836K 0.15% 129
2018
Q1
Sell
-22,164
Closed -$953K 109
2017
Q4
$953K Buy
22,164
+2,294
+12% +$106K 0.32% 47
2017
Q3
$989K Buy
19,870
+940
+5% +$45.5K 0.35% 40
2017
Q2
$907K Buy
+18,930
New +$905K 0.34% 48

Other funds holding SNY

Founders Financial Securities's SNY Position: Q3 2022 in Review

Founders Financial Securities sold out of Sanofi (SNY) in Q3 2022, closing a stake of 16,343 shares — an estimated $818K sold.

Founders Financial Securities first reported a position in SNY in Q2 2017 and held it in 5 quarters. The position peaked at $989K in Q3 2017. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Founders Financial Securities reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Founders Financial Securities sold 16,343 Sanofi shares in Q3 2022, an estimated $818K.
  • Founders Financial Securities first reported a position in Sanofi in Q2 2017 and held it in 5 quarters.
  • Founders Financial Securities's Sanofi position peaked at $989K in Q3 2017.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Founders Financial Securities's 13F filing for Q3 2022, filed 27 Oct 2022.